SOX2 is a promising predictor of relapse and death in advanced stage high-grade serous ovarian cancer patients with residual disease after debulking surgery

od Bååth, Maria, Westbom-Fremer, Sofia, Martin de la Fuente, Laura, Ebbesson, Anna, Davis, Juliette, Malander, Susanne, Måsbäck, Anna, Kannisto, Päivi, Hedenfalk, Ingrid
Wydane w Mol Cell Oncol (2020)